How it works
How Neuralisse works, and what can be checked
A product sold for nerve comfort implies a mechanism. This page asks what route is actually stated for Neuralisse, follows all six ingredients to the bodies that publish on them, and reports what comes back — including the one place where the bottle and the advertisement for it do not use the same word.
No route is stated on the label, and none is required. The front panel reads NERVE SUPPORT FORMULA with three asterisked icons and the FDA disclaimer in full, which is correct practice. The Inside Neuralisse marketing graphic then renders the same bottle as a NEUROPATHY SUPPORT FORMULA. Following the ingredients instead returns four federal fact sheets out of six and one printed figure — which leaves exactly one row that can be assessed from end to end.
The claims, transcribed
Every claim supplied with this product, with where each one appears. Nothing is paraphrased and nothing is left out.
| Claim | Where it appears |
|---|---|
| Nerve Support Formula | Printed on the label, front panel |
| Nerve Health* | Printed on the label, front panel icon |
| Comfort Support* | Printed on the label, front panel icon |
| Nutritional Support | Printed on the label, front panel icon |
| Neuropathy Support Formula | Marketing graphic only — not on the label |
| Nerve-comfort positioning by name. Not a drug. | Seller pack, in its own words |
Four of the six lines are printed on the bottle and all four are structure/function claims carrying an asterisk that leads to the FDA disclaimer. That is how the rule is meant to work, and this label follows it. The fifth line is the problem: Neuropathy Support Formula appears only in a marketing graphic, and neuropathy is a named medical condition rather than a structure or a function.
None of the six describes a route. Nerve support names an area and a direction and commits to nothing measurable — which is a legitimate category of claim, and means a reader who wants to know how the product is supposed to work has to go to the panel instead.
Nerve support on the bottle, neuropathy support in the artwork
This is the finding on this page, and it is a difference of one word between two documents describing the same bottle.
| Document | What the front panel reads | What that is |
|---|---|---|
| The label artwork | NERVE SUPPORT FORMULA*, with an asterisk leading to the FDA disclaimer | A structure/function claim, which a supplement may make |
| The Inside Neuralisse marketing graphic | NEUROPATHY SUPPORT FORMULA, rendered twice, with no asterisk | The name of a medical condition |
“Structure/function claims may describe the role of a nutrient or dietary ingredient intended to affect the normal structure or function of the human body … the disclaimer must state that the product is not intended to “diagnose, treat, cure or prevent any disease,” because only a drug can legally make such a claim.”
U.S. Food and Drug Administration — Structure/Function Claims
Read the last clause of that quotation again: the disclaimer exists “because only a drug can legally make such a claim”. A supplement may say it supports the normal structure or function of the nervous system. It may not say it addresses a named disease. The label stays on the right side of that line. The artwork used to sell it does not.
The label wins, because the label is the product. Nothing on this site repeats the word neuropathy as a claim, and nothing on this site treats it as one. The graphic is published above as the evidence for the finding, not as a description of what the capsule does.
If you have nerve symptoms that nobody has explained
Numbness, tingling and burning in the feet or hands have many causes, and some of them need treating. Unexplained nerve symptoms are a reason to see a clinician, not a reason to buy a supplement. The label itself says to consult a physician before use if you take a medication or have a medical condition. That sentence is on the bottle; the word neuropathy is not.
How this desk checks a mechanism
The method is the same on every product covered here. On this one it gets further than usual on one row and stops early on four.
- 01Start with what the product claimsEvery claim supplied is transcribed first, with the place it appears. On this product that list is short and the label’s half of it is careful: a formula name, three asterisked icons and the FDA disclaimer printed in full.
- 02Separate the label from the artworkWhere the two disagree, the label is the product. That rule matters more here than on anything else this desk has covered, because the two documents use different words for the same bottle.
- 03Ask whether any claim names a routeA structure/function claim names an area and a direction. A mechanism names a process. Nerve support is the first kind: it commits to nothing measurable, which is legitimate and heavily used.
- 04Follow the ingredients to the federal bodies insteadSix names, read against NCCIH’s Herbs at a Glance index and the NIH Office of Dietary Supplements. Four return a fact sheet. Two return nothing, and no dose is published here for either.
- 05Check whether an amount exists to compareOne figure is printed on the panel: 80 mg of magnesium. The five ingredients after the glycinate carry derived ceilings inside a 7.5 mg remainder, not amounts.
- 06Report what completes, and what does notOne row has a name, a printed amount and a federal file that speaks to nerves: magnesium. One more has a file with a dose range to compare against, and loses by a factor of at least a hundred. The rest cannot be assessed, and that is said rather than filled in.
Row by row
| Ingredient | Amount? | Federal fact sheet? | Can a dose comparison be made? |
|---|---|---|---|
| Magnesium (as the glycinate) | Yes — 80 mg of the element declared | Yes — NIH ODS | Yes — against a 420 mg Daily Value and a 350 mg upper limit |
| Alpha lipoic acid | No — ceiling 7.5 mg | No | No |
| Butcher’s broom root extract | No — ceiling 3.7 mg | No | No |
| L-carnitine | No — ceiling 2.5 mg | Yes — NIH ODS | Yes — and the gap is 100 to 1,600 times |
| Turmeric rhizome extract | No — ceiling 1.9 mg | Yes — NCCIH | Partly — NCCIH publishes a conclusion and safety notes, not a dose |
| Coenzyme Q10 (ubiquinone) | No — ceiling 1.5 mg | Yes — NCCIH | Partly — a drug interaction and several null findings, not a dose |
One row out of six completes. Two more can be compared partially, and one of those two — L-carnitine — completes only to lose: NIH ODS records trials at 0.25 to 4 g a day against a ceiling of about 2.5 mg, a gap of roughly a hundred to one thousand six hundred times. Peripheral neuropathy is not among the conditions either NCCIH page covers.
The one row that completes
Magnesium is named, declared at 80 mg, and has a federal fact sheet that speaks directly to nerve function. That is the whole of what can be said about mechanism for this product, and it is more than most products in this series offer.
“Magnesium … helps move calcium and potassium ions across cell membranes, a process that is important to nerve impulse conduction, muscle contraction, and normal heart rhythm … As magnesium deficiency worsens, numbness, tingling, muscle contractions and cramps, seizures … can occur.”
NIH Office of Dietary Supplements — Magnesium: Fact Sheet for Health Professionals — nerve function
Two sentences in that quotation do different work. The first describes a normal physiological role: magnesium helps move calcium and potassium ions across cell membranes, which matters to nerve impulse conduction. A supplement may legitimately be positioned on that. The second describes deficiency — numbness, tingling, cramps — and it is not a statement that extra magnesium relieves those symptoms in someone who already has enough.
So the honest position is narrow and it is worth stating precisely. If a person is short of magnesium, correcting that is documented, and 80 mg a day is a sensible contribution at about 23% of the 350 mg upper limit NIH ODS sets for supplemental magnesium. If a person is not short of magnesium, nothing in the quotation above applies to them, and the other five ingredients in the bottle amount to about 7.5 mg between them. The full row is on the ingredients page.
What can and cannot be said
What this page can state
- Every claim supplied, word for word, and where each one appears.
- That the label itself is careful: a structure/function formula name, three asterisked icons and the FDA disclaimer printed in full.
- That the marketing graphic substitutes the name of a disease into the same bottle, and that the FDA reserves disease claims to drugs.
- The exact amount of magnesium, and both figures NIH ODS publishes to read it against.
- That magnesium has a documented role in nerve impulse conduction, and that the file is about deficiency.
- A bound for each of the other five, and exactly how each bound is derived.
- That four of the six have a federal fact sheet and two return nothing at all.
What this page cannot state
- How the product works. No route is stated anywhere, and none is required.
- That it does not work. Absence of evidence for an ingredient is not evidence against it.
- Anything at all about alpha lipoic acid or butcher’s broom, because neither body this desk reads publishes on them.
- How much of any ingredient other than the declared magnesium a capsule contains.
- Whether the glycinate is the pure chelate the name implies — a sensitivity table on the label page tests that assumption instead.
- Anything about neuropathy. The label does not claim it and this desk will not.
The second column is not an accusation. It is a list of questions the order desk can be asked, and a Certificate of Analysis would answer most of them in one document. The batch page sets out how to ask.
The supplied graphic
A graphic headed How Neuralisse Works was supplied with the product. It is published here because it was supplied, and it is worth noting what it is: an advertisement. Nothing on the label describes a process, and nothing in the material supplied names one. Where the artwork and the bottle disagree, this site prints both and says the bottle is the product.
References
- U.S. Food and Drug Administration (2026). Dietary Supplement Labeling Guide: Chapter IV. Nutrition Labeling.
- U.S. Food and Drug Administration (2026). Structure/Function Claims.
- NIH Office of Dietary Supplements (2026). Magnesium: Fact Sheet for Health Professionals.
- NIH Office of Dietary Supplements (2026). Magnesium: Fact Sheet for Health Professionals — nerve function.
- NIH Office of Dietary Supplements (2023). Carnitine: Fact Sheet for Health Professionals.
- National Center for Complementary and Integrative Health (2025). Turmeric: Usefulness and Safety.
- National Center for Complementary and Integrative Health (2019). Coenzyme Q10.
- Operation Supplement Safety, U.S. Department of Defense (2026). Proprietary blends: What does this mean?.
- U.S. Food and Drug Administration (2026). Questions and Answers on Dietary Supplements.
The graphic headed ‘how it works’
This is the one document in the pack headed with the words how it works, and it is worth reading closely, because what it contains is a routine rather than a mechanism. Nothing in it names a process in the body, an organ or a measurable quantity, and nothing in it says the product acts by anything.
That is not a drafting failure. A dietary supplement may make a structure/function claim and may not make a disease claim, and describing the habit rather than the biology is the safest way to stay on the right side of that line. The label itself does the same thing, and does it well.
So the question becomes a smaller one
Not how does it work, which nothing published answers, but which of the six rows can be assessed at all. Four of the six have a federal fact sheet, which is the best hit rate this desk has recorded, and one of them — magnesium — has a documented role in nerve function. The rest of this page is that answer with the working shown.
Read the blend row before you decide
Thirty capsules, one a day. The panel declares 80 mg of magnesium at 19% of the Daily Value, and a 575 mg blend of six ingredients. The magnesium declaration fixes the weight of the first ingredient at about 567.5 mg, which leaves roughly 7.5 mg for the other five together. No price appears anywhere but the checkout.
- Guarantee as printed at checkout
- 80 mg magnesium, 19% of the Daily Value
- Returns to 4 Times Square, Floor 22, New York, NY 10036, USA
No price appears in any document supplied to this desk, as of October 11, 2026, so none is printed here. The checkout screen is the only place a price exists. Questions first? Every published contact route is here.
Keep reading
Authorship and review
Who wrote and checked this page
What this page was checked against
- The label artwork, read at 2× and transcribed character for character. Where the label and the marketing disagree, the label is printed.
- The seller pack, quoted rather than paraphrased, and identified as marketing wherever it is used.
- The published sources listed in the references on this page. Every one was opened and read; none is cited from memory.
- The arithmetic, shown in full. Every per-ingredient figure other than the magnesium is a ceiling derived from one printed number, never a measured amount.
- Nothing else. Any fact that was not supplied is recorded as not published rather than filled in.
Last updated October 11, 2026. A highlighted slot is a value no human has supplied yet. Who reviews these pages?